Neal Kleiman, MD — The Methodist Hospital, Baylor College of Medicine
Faculty Disclosure
- Grant and/or Research Support: Millennium Therapeutics; The Medicines Company
- Consultant: Sanofi-Aventis
Learning Objectives
- Review the historical background of heparin, its activities, and dosage
- Describe the clinical features of heparin-induced thrombocytopenia
- Discuss low molecular weight heparins and pentasaccharide: comparative pharmacology and clinical trial results